- Previous Close
3,480.00 - Open
3,540.00 - Bid 3,435.00 x --
- Ask 3,480.00 x --
- Day's Range
3,430.00 - 3,540.00 - 52 Week Range
3,290.00 - 6,090.00 - Volume
35,071 - Avg. Volume
158,609 - Market Cap (intraday)
52.247B - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield 130.00 (3.77%)
- Ex-Dividend Date Dec 27, 2023
- 1y Target Est
--
Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. was founded in 1992 and is headquartered in Seoul, South Korea.
www.arlico.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 260660.KQ
View MorePerformance Overview: 260660.KQ
Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 260660.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 260660.KQ
View MoreValuation Measures
Market Cap
51.72B
Enterprise Value
81.46B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.28
Price/Book (mrq)
0.62
Enterprise Value/Revenue
0.45
Enterprise Value/EBITDA
1.16
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.96%
Return on Assets (ttm)
-4.18%
Return on Equity (ttm)
-10.05%
Revenue (ttm)
178.83B
Net Income Avi to Common (ttm)
-8.86B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
17.68B
Total Debt/Equity (mrq)
57.45%
Levered Free Cash Flow (ttm)
-22.51B